Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

What can target kidney fibrosis?

Irina A Leaf1, Jeremy S Duffield1,2

  • 1Research & Development, Biogen, Cambridge, MA, USA.

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
|April 10, 2017
PubMed
Summary

Fibrosis in chronic kidney disease is driven by fibroblast precursors and innate immune signaling. Targeting these pathways, alongside metabolic dysfunction, offers new therapeutic strategies beyond TGFβ inhibition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

3'-end ligation sequencing is a sensitive method to detect DNA nicks at potential sites of off-target activity induced by prime editors.

Genome research·2025
Same author

MANF stimulates autophagy and restores mitochondrial homeostasis to treat autosomal dominant tubulointerstitial kidney disease in mice.

Nature communications·2023
Same author

Resolved: EMT Produces Fibroblasts in the Kidney.

Journal of the American Society of Nephrology : JASN·2023
Same author

MANF stimulates autophagy and restores mitochondrial homeostasis to treat toxic proteinopathy.

bioRxiv : the preprint server for biology·2023
Same author

The glomerular filtration barrier: a structural target for novel kidney therapies.

Nature reviews. Drug discovery·2021
Same author

Ultrabright plasmonic fluor nanolabel-enabled detection of a urinary ER stress biomarker in autosomal dominant tubulointerstitial kidney disease.

American journal of physiology. Renal physiology·2021

Area of Science:

  • Nephrology
  • Immunology
  • Cell Biology

Background:

  • Fibrosis is a hallmark of chronic kidney disease (CKD) and predicts disease progression.
  • Pathological matrix deposition in kidney structures contributes to nephron and vascular damage.
  • Fibroblast precursors, including pericytes, stem cells, podocytes, and mesangial cells, are central to fibrogenesis.

Purpose of the Study:

  • To explore the role of fibroblast precursors and innate immune signaling in kidney fibrosis.
  • To investigate the interplay between cellular crosstalk, metabolic dysfunction, and fibrogenesis.
  • To identify novel therapeutic targets for kidney fibrosis.

Main Methods:

  • Identification of major fibroblast precursor cell populations in the kidney.
  • Analysis of innate immune signaling pathways in fibroblast precursors.
Keywords:
anti-fibroticsclinical trialsinnate immunitymetabolism

Related Experiment Videos

  • Review of genomic and genetic studies implicating cellular dysfunction and crosstalk.

    • Main Results:

    • Fibroblast precursors act as matrix-producing and innate immune surveillance cells.
    • Innate immune signaling is intrinsically linked to the fibrogenic process.
    • Defective cellular responses in solute transport, metabolism, and vascular homeostasis contribute to fibrosis.
    • Cellular crosstalk is crucial for the development of kidney fibrosis.

    Conclusions:

    • Targeting innate immune signaling and metabolic dysfunction presents viable therapeutic avenues for kidney fibrosis.
    • Novel therapies may move beyond TGFβ inhibition to address complex fibrotic mechanisms.